Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Acadia Pharmaceutica (NQ: ACAD ) 15.30 +0.13 (+0.86%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Acadia Pharmaceutica < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > Reassuring Market Adoption of Daybue Fuels Acadia's Strategic Advancements, Analysts Boost Price Targets July 14, 2023 Acadia Pharmaceuticals Inc (NASDAQ: ACAD) expanded its current licensing agreement for trofinetide with Neuren Pharmaceuticals to acquire ex-North American Via Benzinga Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session July 14, 2023 Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement. Via Benzinga Crude Oil Down 2%; Citigroup Profit Tops Estimates July 14, 2023 U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Friday. The Dow traded up 0.31% to 34,501.62 while the NASDAQ rose 0.36% to 14,188.86. The S&P 500, also... Via Benzinga Why Acadia Pharmaceuticals Stock Is Soaring Today July 14, 2023 Investors are cheering Acadia's latest news. Via The Motley Fool Where ACADIA Pharmaceuticals Stands With Analysts July 11, 2023 Via Benzinga Acadia's Newest Drug Just Obliterated Sales Expectations; Shares Hit Two-Year High July 14, 2023 The company also expanded its commercial rights to the drug and added another to its line-up. Via Investor's Business Daily UnitedHealth, Elanco Animal Health And Other Big Stocks Moving Higher On Friday July 14, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session. Via Benzinga Why Are Acadia Pharmaceuticals Shares Trading Higher Today? July 14, 2023 Acadia Pharmaceuticals Inc (NASDAQ: ACAD) shares are trading higher after the company expanded its current licensing agreement for trofinetide with Neuren Pharmaceuticals to acquire ex-North American Via Benzinga Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket July 14, 2023 Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday. Via Benzinga 11 Analysts Have This to Say About ACADIA Pharmaceuticals June 14, 2023 Via Benzinga Analyst Ratings for ACADIA Pharmaceuticals June 14, 2023 Via Benzinga ACADIA Pharmaceuticals's Return On Capital Employed Insights May 23, 2023 Via Benzinga What 22 Analyst Ratings Have To Say About ACADIA Pharmaceuticals May 09, 2023 Via Benzinga Microsoft To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Friday July 14, 2023 Keybanc boosted the price target for Spotify Technology S.A. (NYSE: SPOT) from $180 to $205. Keybanc analyst Justin Patterson maintained an Overweight rating. Spotify shares rose 0.9% to $172.68 in... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday July 14, 2023 It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday! Via InvestorPlace Why These 2 Biotech Stocks Made Big Moves Late Thursday July 13, 2023 Markets kept powering higher on the day. Via The Motley Fool 12 Health Care Stocks Moving In Thursday's After-Market Session July 13, 2023 Via Benzinga Acadia Pharmaceuticals Acquires Ex-North American Rights to Trofinetide and Global Rights to Neuren’s NNZ-2591 in Rett Syndrome and Fragile X Syndrome July 13, 2023 From Acadia Pharmaceuticals Inc. Via Business Wire 10 Health Care Stocks Whale Activity In Today's Session June 29, 2023 Via Benzinga Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 26, 2023 From Acadia Pharmaceuticals Inc. Via Business Wire Strategic Fit of ACP-101 Promises Future Revenue Growth for Acadia Pharmaceuticals: Analyst June 14, 2023 Tuesday, Acadia Pharmaceuticals Inc (NASDAQ: ACAD) announced the addition of a new Phase 3 development candidate to its rare disease portfolio, ACP-101 (intranasal carbetocin), for hyperphagia (a false... Via Benzinga Acadia Pharmaceuticals Announces Phase 3 Development Candidate ACP-101 (intranasal carbetocin) for Prader-Willi Syndrome June 13, 2023 From Acadia Pharmaceuticals Inc. Via Business Wire Nature Medicine Publishes Results from Pivotal Phase 3 LAVENDER™ Study Evaluating DAYBUE™ (trofinetide) Efficacy and Safety in Patients with Rett Syndrome June 08, 2023 From Acadia Pharmaceuticals Inc. Via Business Wire 3 Penny Stocks That Could Skyrocket in the Next 12 Months June 07, 2023 Find the top penny stocks to buy, and you can make a fortune. Pick the wrong one and there are also plenty of horrors. Via InvestorPlace Acadia Pharmaceuticals to Present at the Jefferies Global Healthcare Conference June 01, 2023 From Acadia Pharmaceuticals Inc. Via Business Wire Over $5M Bet On Southwest Gas? Check Out These 4 Stocks Insiders Are Buying May 25, 2023 Although US stocks closed lower on Wednesday, there were a few notable insider trades. Via Benzinga ACADIA ALERT: Bragar Eagel & Squire, P.C. is Investigating Acadia Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm May 24, 2023 From Bragar Eagel & Squire, P.C. Via Business Wire ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) Records 52-Week High Tuesday Morning May 23, 2023 Via Investor Brand Network Top 5 Health Care Stocks That Should Keep You Up At Night May 23, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga Acadia Pharmaceuticals Reports First Quarter 2023 Financial Results and Operating Overview May 08, 2023 From Acadia Pharmaceuticals Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.